Recent Partnerships Grünenthal has recently established partnerships with several companies such as Catalent, RealizedCare, and Kyowa Kirin, indicating opportunities for collaborative sales ventures and potential cross-selling of products.

Global Presence With affiliates in 27 countries and products available in approximately 100 countries, Grünenthal's extensive global reach provides avenues for expanding sales territories and entering new markets.

Innovative Product Pipeline The collaboration with companies like Catalent on small molecule development and the partnership for the global rights to Zomig showcase Grünenthal's focus on innovative products, presenting potential for differentiated sales offerings.

Focused Vision Grünenthal's vision of a world free of pain aligns with the healthcare industry's increasing emphasis on patient well-being, creating sales opportunities by addressing the growing demand for effective pain management solutions.

Key Acquisitions Acquiring assets like Nexium™ and Vimovo™ from AstraZeneca in previous years demonstrates Grünenthal's strategic approach to enhancing its product portfolio, suggesting potential sales growth through diversified offerings.